LogicBio Therapeutics has got off a $45 million series B funding round.

Australia’s Medibio reported promising results for a noninvasive diagnostic tool for post-traumatic stress disorder.

It’s time again to call on you to nominate your Fierce 15 for 2017.

Xenon and partner Teva’s experimental pain drug TV-45070 has missed all endpoints in patients with pain following shingles.

New York City's bid to become a life sciences hotspot took another step forward this week with the help of a $5 million grant from the mayor's office.

Patrick Soon-Shiong's outfit NantCell will acquire Altor Bioscience for two bucks a share.

The third BioGeneration Ventures Fund has hit $74 million as it attracts new investors.

Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders

Digital diabetes management player Glooko raised $35 million to further develop its technology and expand in a number of markets.

Merck is mulling whether to file its CETP medication anacetrapib after posting some surprising positive topline data from the Reveal test.